INOVIO Announces Pricing of Approximately $75 Million Public Offering

The Quick Take
PLYMOUTH MEETING, Pa., Nov. 5, 2026 /PRNewswire/ -- INOVIO Pharmaceuticals, Inc. (Nasdaq: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases, today announced the...
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to PR Newswire M&A.
Related
Local
Samen voor een door AI aangedreven stedelijke toekomst: Dahua Technology presenteert praktische AIoT-oplossingen op SCEWC 2026.
BARCELONA, Spanje, 6 november 2026 /PRNewswire/ -- Dahua Technology, een wereldwijd toonaangevende aanbieder van op video gerichte AIoT-oplossingen en…
Business
La société Sasken sélectionnée pour soutenir le programme de plateforme de connectabilité stratégique d'une entreprise européenne leader des logiciels automobiles
L'engagement pluriannuel porte sur les services logiciels, matériels et de validation relatifs aux unités de contrôle télématiques de nouvelle génération…
Business
America turns on Trump’s tech cheerleaders
Silicon Valley elites and AI executives plot new political strategy after alliance with US president backfires in midterms
Business
Who’s in the line of fire after the midterm drubbing?
The Trump administration reckons with the Democratic Party’s emphatic victory in the US midterms
